Disease | porphyria |
Comorbidity | C0162565|acute intermittent porphyria |
Sentences | 8 |
PubMedID- 24603363 | Pbgd is associated with acute intermittent porphyria, a hereditary autosomal dominant disorder, caused due to mutations in human pbgd (hpbgd) resulting in elevated levels of the heme precursors ala (5-aminolevulinic acid) and pbg in the urine [5]. |
PubMedID- 25114422 | Hypokalemic paralysis (7.5%) and acute intermittent porphyria (4.5%) were also encountered in considerable numbers. |
PubMedID- 21358970 | Acute intermittent porphyria (aip) is associated with functional defects in both the central and peripheral nervous systems [271]. |
PubMedID- 25697467 | Acute porphyria was diagnosed, with acute intermittent porphyria as the working diagnosis. |
PubMedID- 24700519 | Clinical phenotypes are classified as follows: (1) acute porphyrias with neurovisceral symptoms: acute intermittent porphyria; delta amino-levulinic acid hydratase deficiency porphyria; hereditary coproporphyria; and variegate porphyria and (2) cutaneous porphyrias with skin blistering and photosensitivity: porphyria cutanea tarda; congenital erythropoietic porphyria; hepatoerythropoietic porphyria and both erythropoietic protoporphyrias: autosomal dominant and x-linked. |
PubMedID- 22704060 | Acute intermittent porphyria (aip) is an autosomal dominant inherited disease clinically characterized by life-threatening acute neurologic attacks and is biochemically defined by partial deficiency of porphobilinogen deaminase (pbgd) activity in the liver. |
PubMedID- 21836671 | Acute intermittent porphyria (aip) has a triad of symptoms (abdominal pain, neuropathy and mental changes) and porphobilinogen in the urine. |
PubMedID- 21687623 | Acute intermittent porphyria (aip) is an autosomal dominant disorder caused by deficiency of porphobilinogen deaminase (pbgd), which is involved in the hepatic heme biosynthesis [1]. |
Page: 1